Safety Study of BLS-M22 in Healthy Volunteers

Exclusion Criteria

• •1. Subject has a clinically significant disease or history of liver, kidney, cardiovascular system, endocrine system, musculoskeletal system, digestive system, respiratory system, neuropsychiatry, blood∙tumor system.
• •2. Hypersensitive to the lactobacillus-containing food (such as yogurt) and the lactobacillus preparation and the investigational drug
• •3. Subject has received a investigational drug or a bioequivalence study drug within 90 days of the randomization
• •4. Subject has received steroids or other immunosuppressive drugs within 30 days of randomization
• •5. Positive serum test results for hepatitis C virus, hepatitis B virus, HIV or syphilis
• •6. Those who do not use of a medically acceptable method of contraception during the trial, or who plan to provide sperm
• •7. Pregnant women
• •8. Subject has genetic problems such as galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption
• •9. Subject has abnormal clinical laboratory test results
• •10. Any other ineligible condition at the discretion of the investigator that would be ineligible to participate the study